Janssen Pharmaceutical K.k.
Clinical trials sponsored by Janssen Pharmaceutical K.k., explained in plain language.
-
New hope for stubborn lung infections that resist standard treatments
Disease control CompletedThis study tested whether adding a drug called bedaquiline to standard antibiotics works better for adults with hard-to-treat MAC lung infections. Researchers compared bedaquiline against another standard drug in 129 participants over 24 weeks. The main goal was to see if the new…
Phase: PHASE2, PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for kids with rare, deadly lung disease
Disease control CompletedThis study tested a drug called macitentan in Japanese children with pulmonary arterial hypertension (PAH), a serious condition where high blood pressure damages the lungs and heart. The main goal was to see if taking the drug for 24 weeks improved how well the heart and lungs wo…
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for japanese patients battling Tough-to-Treat blood cancer
Disease control CompletedThis study tested the safety of an experimental drug called talquetamab in 15 Japanese patients with multiple myeloma that had returned or stopped responding to standard treatments. The main goal was to see how well patients tolerated the drug at a specific dose level. Researcher…
Phase: PHASE1 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
New drug shows promise for controlling debilitating Crohn's symptoms
Disease control CompletedThis study tested the safety and effectiveness of guselkumab, an injectable medication, in adults with moderate to severe Crohn's disease. The 38 participants had active symptoms and had not responded well to previous treatments. Researchers monitored side effects and whether the…
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
Massive study tracks 979 men battling advanced prostate cancer
Knowledge-focused CompletedThis study was a registry that observed and collected information on nearly 1,000 Japanese men with advanced, high-risk prostate cancer that had already spread. The goal was to understand how patients fare in real-world settings, tracking their survival, cancer progression, and q…
Sponsor: Janssen Pharmaceutical K.K. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Doctors track Real-World treatment for painful skin condition
Knowledge-focused CompletedThis study aimed to understand how palmoplantar pustulosis (PPP), a chronic skin condition causing painful blisters on hands and feet, is treated in real-world Japanese clinics. Researchers observed 276 patients already starting or receiving standard systemic medications to see h…
Sponsor: Janssen Pharmaceutical K.K. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC